Evgeny Tankhilevich
Evgeny Tankhilevich has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Andrew R. Leach
European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SD, United Kingdom
3 shared publications Carolina Berg
Astra-Zeneca Protein Science, Structure and Biophysics, Discovery Sciences, BioPharmaceuticals R&D Mölndal, 431 83
2 shared publicationsIan Barrett
Astra-Zeneca Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D Cambridge, CB2 0AA
2 shared publications- Lovisa Holmberg Schiavone
Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden
2 shared publications Sergio Martinez Cuesta
Astra-Zeneca Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D Cambridge, CB2 0AA
2 shared publications- Ahmed El Marjou
Protein Expression and Purification Core Facility Institut Curie PSL Research University UMR 144 CNRS 75005 Paris France
1 shared publication
Latest Publications
- Open Access
- 29 September 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (11)
EXPERT: A practical and forward-looking guide to capturing protein expression and purification metadata to develop machine learning models
- 29 September 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (11)
Open AccessEXPERT: A practical and forward-looking guide to capturing protein expression and purification metadata to develop machine learning models
- Open Access
- 2 January 2026
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 42 (1)
RP3Net: a deep learning model for predicting recombinant protein production in Escherichia coli
Motivation: Recombinant protein expression can be a limiting step in the production of protein reagents for drug discovery and other biotechnology applications. We introduce RP3Net (Recombinant Protein Production Prediction Network), an AI model of small-scale heterologous soluble protein expression in Escherichia coli. RP3Net utilizes the most recent protein and genomic foundational models. A curated dataset of internal experimental results from AstraZeneca and publicly available data from the Structural Genomics Consortium was used for training, validation and testing of RP3Net. Results: RP3Net achieves an increase in area under the receiver operator curve (AUROC) of 0.15, compared to a baseline model. When experimentally validated on an independent, prospective, manually selected set of 97 constructs, RP3Net outperformed currently available models, with an AUROC of 0.83, delivering accurate predictions in 77% of the cases, and correctly identifying successfully expressing constructs in 92% of cases. Availability and implementation: The model, along with installation and running instructions, is available under an MIT licence at https://github.com/RP3Net/RP3Net, DOI 10.5281/zenodo.17243498.
- 2 January 2026
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 42 (1)
Open AccessRP3Net: a deep learning model for predicting recombinant protein production in Escherichia coli
Motivation: Recombinant protein expression can be a limiting step in the production of protein reagents for drug discovery and other biotechnology applications. We introduce RP3Net (Recombinant Protein Production Prediction Network), an AI model of small-scale heterologous soluble protein expression in Escherichia coli. RP3Net utilizes the most recent protein and genomic foundational models. A curated dataset of internal experimental results from AstraZeneca and publicly available data from the Structural Genomics Consortium was used for training, validation and testing of RP3Net. Results: RP3Net achieves an increase in area under the receiver operator curve (AUROC) of 0.15, compared to a baseline model. When experimentally validated on an independent, prospective, manually selected set of 97 constructs, RP3Net outperformed currently available models, with an AUROC of 0.83, delivering accurate predictions in 77% of the cases, and correctly identifying successfully expressing constructs in 92% of cases. Availability and implementation: The model, along with installation and running instructions, is available under an MIT licence at https://github.com/RP3Net/RP3Net, DOI 10.5281/zenodo.17243498.
- Open Access
RP3Net: a deep learning model for predicting recombinant protein production in Escherichia coli
Recombinant protein expression can be a limiting step in the production of protein reagents for drug discovery and other biotechnology applications. We introduce RP3Net (Recombinant Protein Production Prediction Network), an AI model of small-scale heterologous soluble protein expression in Escherichia coli . RP3Net utilizes the most recent protein and genomic foundational models. A curated dataset of internal experimental results from AstraZeneca (AZ) and publicly available data from the Structural Genomics Consortium (SGC) was used for training, validation and testing of RP3Net. Set Transformer Pooling (STP) aggregation and Meta Label Correction (MLC) with large scale purification data enabled RP3Net to improve Area Under Receiver Operator Curve (AUROC) by 0.15, compared to the baseline model. When experimentally validated on an independent, manually selected set of 97 constructs, RP3Net outperformed currently available models, with an AUROC of 0.83, delivering accurate predictions in 77% of the cases, and correctly identifying successfully expressing constructs in 92% of cases.
Open AccessRP3Net: a deep learning model for predicting recombinant protein production in Escherichia coli
Recombinant protein expression can be a limiting step in the production of protein reagents for drug discovery and other biotechnology applications. We introduce RP3Net (Recombinant Protein Production Prediction Network), an AI model of small-scale heterologous soluble protein expression in Escherichia coli . RP3Net utilizes the most recent protein and genomic foundational models. A curated dataset of internal experimental results from AstraZeneca (AZ) and publicly available data from the Structural Genomics Consortium (SGC) was used for training, validation and testing of RP3Net. Set Transformer Pooling (STP) aggregation and Meta Label Correction (MLC) with large scale purification data enabled RP3Net to improve Area Under Receiver Operator Curve (AUROC) by 0.15, compared to the baseline model. When experimentally validated on an independent, manually selected set of 97 constructs, RP3Net outperformed currently available models, with an AUROC of 0.83, delivering accurate predictions in 77% of the cases, and correctly identifying successfully expressing constructs in 92% of cases.